Searle & CO. raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 533.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 6,332 shares of the company’s stock after purchasing an additional 5,332 shares during the quarter. Eli Lilly and Company makes up approximately 1.0% of Searle & […]
A number of research firms have changed their ratings and price targets for Eli Lilly and Company (NYSE: LLY): 5/1/2024 – Eli Lilly and Company had its price target raised by analysts at JPMorgan Chase & Co. from $850.00 to $900.00. They now have an “overweight” rating on the stock. 5/1/2024 – Eli Lilly and […]
Cozad Asset Management Inc. lowered its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 3,109 shares of the company’s stock after selling 191 shares during the quarter. Cozad Asset Management […]
Oakwell Private Wealth Management LLC purchased a new stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 431 shares of the company’s stock, valued at approximately $251,000. Other hedge funds and other […]
Oakwell Private Wealth Management LLC acquired a new position in Eli Lilly and Company (NYSE:LLY – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 431 shares of the company’s stock, valued at approximately $251,000. A number of other institutional […]